Amicus Therapeutics Inc (FOLD)
9.80
+0.07
(+0.72%)
USD |
NASDAQ |
Dec 20, 16:00
9.80
0.00 (0.00%)
After-Hours: 20:00
Amicus Therapeutics Profit Margin (Quarterly): -4.75% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | -503.6% |
| Immuneering Corp | -- |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Insmed Inc | -236.0% |
| Ionis Pharmaceuticals Inc | -105.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -71.17% |
| Return on Assets | -13.78% |
| Return on Invested Capital | -19.50% |
| Gross Profit Margin (Quarterly) | 90.62% |
| Operating Margin (Quarterly) | 17.53% |
| Return on Net Operating Assets | -24.20% |